The FWC has found Sydney Trains does not have to fund devices used to treat employees' sleep apnoea, but has suggested a review of arrangements with the employer's external health assessors after workers diagnosed with the condition had to pay up to $4000 for the anti-snoring technology.
Having trouble using your subscription? Contact us for help or check our FAQ page here for answers to commonly asked questions.
Non subscribers: Access Workplace Express by starting your subscription here.
Haven't seen Workplace Express before? For a 28-day free trial sign up here.
Go back to our homepage here.